ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 186 filers reported holding ASCENDIS PHARMA A/S in Q4 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,132,499 | -22.8% | 8,304 | -14.5% | 0.02% | -42.5% |
Q1 2024 | $1,467,861 | -12.7% | 9,710 | -27.2% | 0.04% | -28.6% |
Q4 2023 | $1,680,929 | +684.7% | 13,346 | +456.1% | 0.06% | +600.0% |
Q2 2023 | $214,200 | -94.2% | 2,400 | -94.0% | 0.01% | -95.0% |
Q2 2022 | $3,712,000 | +1269.7% | 39,938 | +2249.3% | 0.16% | +700.0% |
Q3 2021 | $271,000 | – | 1,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |